Tag: FDA regulations

Changes Being Effected (CBE) vs Prior Approval Supplements (PAS)

September 13, 2025

Changes Being Effected (CBE) vs Prior Approval Supplements (PAS) Navigating FDA Post-Approval Changes: CBE vs PAS Introduction: Why Post-Approval Change Pathways Matter Once a drug receives FDA approval, maintaining up-to-date and compliant documentation for any manufacturing, labeling, or quality changes is essential. The FDA provides two key mechanisms for implementing such changes in the U.S….

Post-Approval Commitments, Regulatory Submissions and Approvals

Regulatory Guidelines for Clinical Trials and Drug Approvals: A Global Overview

May 14, 2025

digi

Regulatory Guidelines for Clinical Trials and Drug Approvals: A Global Overview Comprehensive Guide to Regulatory Guidelines for Clinical Trials and Global Drug Approvals Regulatory guidelines ensure the safe and ethical development of new therapies across the globe. From clinical trial initiation to post-marketing surveillance, authorities like the FDA, EMA, CDSCO, PMDA, MHRA, and others establish…

Regulatory Guidelines

U.S. FDA Regulations for Clinical Trials and Drug Approvals: A Complete Guide

May 8, 2025

digi

U.S. FDA Regulations for Clinical Trials and Drug Approvals: A Complete Guide Complete Overview of U.S. FDA Regulations for Clinical Trials and Drug Development The U.S. Food and Drug Administration (FDA) is a global leader in regulating clinical research, drug development, and therapeutic approvals. Its comprehensive framework ensures that products entering the market meet stringent…

Regulatory Guidelines, U.S. FDA Regulations